Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,146 public trials 2,034 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Recruiting

A Study of Bexarotene Combined With Radiotherapy in People With Mycosis Fungoides

NCT05296304

Conditions
Cutaneous T-Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities) New York, United States
  • Memorial Sloan Kettering Nassau (Limited Protocol Activites) Rockville Centre, New York, United States
View Trial Details
Recruiting

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

NCT05892718

Conditions
Advanced Solid Tumor, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Hematology-Oncology Associates of the Treasure Coast Port Saint Lucie, Florida, United States
  • Carolina BioOncology Huntersville, North Carolina, United States
  • Greenville Hospital System University Medical Center (ITOR) Greenville, South Carolina, United States
  • UT Southwestern Medical Center Dallas, Texas, United States
View Trial Details
Recruiting

A Study of Selinexor (Seli) + Low-dose Dexamethasone (LDD) in Penta-refractory Multiple Myeloma (MM), Seli and Bortezomib + LDD in Triple-class Refractory MM.

NCT04414475

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University General Hospital of Patras Pátrai, Achaia, Greece
  • General Hospital of Athens "Alexandra" Attiki, Athens, Greece
  • General Hospital of Athens "Evangelismos" Athens, Attica, Greece
  • Theageneion Cancer Hospital Thessaloniki, Greece
View all 16 locations
View Trial Details
Recruiting

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

NCT05180097

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
Locations
  • Concord Repatriation General Hospital Concord, New South Wales, Australia
  • Shoalhaven Cancer Care Centre Nowra, New South Wales, Australia
  • Wollongong Hospital Wollongong, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
View all 18 locations
View Trial Details
Recruiting

Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma

NCT05633615

Conditions
Diffuse Large B-cell Lymphoma, Grade 3b Follicular Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Highlands Oncology Group - Fayetteville Fayetteville, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 87 locations
View Trial Details

Related conditions